STROBE-based methodology for detection of adverse events across multiple communities

Margarita Sordo; Judith Colecchi; Anil Dubey; Vivian Gainer; Shawn N Murphy

STROBE-based methodology for detection of adverse events across multiple communities

AMIA Annu Symp Proc. 2008 Nov 6:1144.

Authors

Margarita Sordo¹, Judith Colecchi, Anil Dubey, Vivian Gainer, Shawn N Murphy

Affiliation

¹ Massachusetts General Hospital, Partners Healthcare, Boston, MA, USA.

PMID: 18998965

Abstract

Partners Healthcare is one of five institutions in conjunction with eHealth Initiative (eHI) and the FDA that is collaborating in a nation-wide effort to develop novel health information technology tools to create an active drug safety surveillance system across the U.S. The STROBE statement serves as the standard for the definition of a structured, systematic, reproducible approach for detecting both the risks and benefits of drug treatments in multiple settings.

MeSH terms

Adverse Drug Reaction Reporting Systems / organization & administration*
Community Networks / organization & administration*
Drug-Related Side Effects and Adverse Reactions / classification*
Humans
Information Dissemination / methods*
Massachusetts
Practice Guidelines as Topic*
Risk Assessment / methods
Risk Factors